[1] 赵万霞,王何婷,任月秋,等.糖尿病肾病早期标志物研究新进展[J]. 国际内分泌代谢杂志,2018,38(3):192-195. [2] Maqbool M, Cooper ME, Jandeleit-Dahm KAM.Cardiovascular disease and diabetic kidney disease[J]. Semin Nephrol, 2018, 38(3): 217-232. [3] Kourtidou C, Stangou M, Marinaki S, et al.Novel cardiovascular risk factors in patients with diabetic kidney disease[J]. Int J Mol Sci, 2021, 22(20): 11196. [4] 史张,刘崎.影像组学技术方法的研究及挑战[J]. 放射学实践,2018,33(6):633-636. [5] 刘再毅. 影像组学的临床价值及面临的挑战[J]. 协和医学杂志,2018,9(4):295-297. [6] DiSantostefano J. International Classification of Diseases 10th Revision (ICD-10)[J]. J Nurse Pract, 2009, 5(1): 56-57. [7] Jankowski J, Floege J, Fliser D, et al.Cardiovascular disease in chronic kidney disease[J].Circulation,2021,143(11): 1157-1172. [8] Whaley-Connell A, Nistala R, Chaudhary K.The importance of early identification of chronic kidney disease[J]. Mo Med, 2011, 108(1): 25-28. [9] Kofod DH, Carlson N, Ballegaard EF, et al.Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study[J]. Cardiovasc Diabetol, 2023, 22(1): 140. [10] 浦丹凤,王霞娟,马坚,等.糖尿病视网膜病变合并糖尿病肾病的危险因素及其预测价值[J]. 中华老年多器官疾病杂志,2019,18(1):30-35. [11] 刘超,鲁际.影像组学的兴起及其应用进展[J]. 海南医学, 2018,29(15):2164-2166. [12] Pujadas ER, Raisi-Estabragh Z, Szabo L, et al.Prediction of incident cardiovascular events using machine learning and CMR radiomics[J]. Eur Radiol, 2023, 33(5): 3488-3500. [13] Bandara MS, Gurunayaka B, Lakraj G, et al.Ultrasound based radiomics features of chronic kidney disease[J]. Acad Radiol, 2022, 29(2): 229-235. [14] Chinnadurai R,Chrysochou C,Kalra PA.Increased risk for cardiovascular events in patients with diabetic kidney disease and non-alcoholic fatty liver disease[J].Nephron,2019,141(1): 24-30. [15] Müller-Werdan U.Cardiovascular prevention in old age—Cardiovascular prevention of ageing?[J].Z Gerontol Geriatr, 2022, 55(6): 461-464. [16] Kramer CK, Zinman B, Retnakaran R.Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis[J]. Ann Intern Med, 2013, 159(11): 758-769. [17] Borén J, Chapman MJ, Krauss RM, et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2020, 41(24): 2313-2330. [18] Cahn A, Wiviott SD, Mosenzon O, et al.Association of baseline HbA1c with cardiovascular and renal outcomes: analyses from DECLARE-TIMI 58[J]. Diabetes Care, 2022, 45(4): 938-946. [19] Tsao CW, Aday AW, Almarzooq ZI, et al.Heart disease and stroke statistics—2023 update: a report from the American Heart Association[J]. Circulation, 2023, 147(8): e93-e621. |